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Abstract
Introduction: Swaziland’s severe HIV epidemic inspired an early national response since the late 1980s, and regular
reporting of program outcomes since the onset of a national antiretroviral treatment (ART) program in 2004. We
assessed effectiveness outcomes and mortality trends in relation to ART, HIV testing and counseling (HTC),
tuberculosis (TB) and prevention of mother to child transmission (PMTCT).
Methods: Data triangulated include intervention coverage and outcomes according to program registries
(2001-2010), hospital admissions and deaths disaggregated by age and sex (2001-2010) and population mortality
estimates from the 1997 and 2007 censuses and the 2007 demographic and health survey.
Results: By 2010, ART reached 70% of the estimated number of people living with HIV/AIDS with CD4<350/mm3,
with progressively improving patient retention and survival. As of 2010, 88% of health facilities providing antenatal
care offered comprehensive PMTCT services. The HTC program recorded a halving in the proportion of adults tested
who were HIV-infected; similarly HIV infection rates among HIV-exposed babies halved from 2007 to 2010. Case
fatality rates among hospital patients diagnosed with HIV/AIDS started to decrease from 2005–6 in adults and
especially in children, contrasting with stable case fatality for other causes including TB. All-cause child in-patient
case fatality rates started to decrease from 2005–6. TB case notifications as well as rates of HIV/TB co-infection
among notified TB patients continued a steady increase through 2010, while coverage of HIV testing and CPT for co-
infected patients increased to above 80%.
Conclusion: Against a background of high, but stable HIV prevalence and decreasing HIV incidence, we
documented early evidence of a mortality decline associated with the expanded national HIV response since 2004.
Attribution of impact to specific interventions (versus natural epidemic dynamics) will require additional data from
future household surveys, and improved routine (program, surveillance, and hospital) data at district level.
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Background
With increasing global momentum and HIV financing brought
about with the “3 by 5” initiative [1,2] and creation of the Global
Fund to fight AIDS, tuberculosis and malaria (GF) in 2002, low-
and middle-income countries have rapidly scaled-up HIV
Testing and Counseling (HTC) as entry point to treatment and
care, as well as Antiretroviral Therapy (ART), HIV-TB and
Prevention of Mother to Child Transmission (PMTCT)
programs. More recent initiatives by the World Health
Organization (WHO), the Joint United Nations Programme on
HIV/AIDS (UNAIDS) and partners have set ambitious goals
and targets to achieve universal access to comprehensive HIV
care by 2015 [3–5].
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To monitor and evaluate the health impact of intensified
program efforts, WHO, UNAIDS, the GF and partners provide
Monitoring and Evaluation (M & E) guidance for national HIV/
AIDS programs to report on policy development,
implementation and programmatic progress of HTC, ART, HIV-
TB and PMTCT services [3–9]. These Global Health Initiatives
developed guidance on ‘triangulating’ a combination of relevant
existing data sources to understand national and local HIV
epidemics and evaluate program outcomes and impact [10,11].
The triangulation approach was initially developed and tested
in two countries with high HIV prevalence and relatively
advanced program responses, Botswana [12–15] and Malawi
[16–19]. Other examples of successful HIV data triangulation
include Ukraine, Republic of Moldova and Estonia [20,21].
This article presents the results of a data triangulation for key
HIV and TB interventions in Swaziland [11,22]. A program
progress evaluation using triangulation is timely for Swaziland
for three reasons. First, Swaziland is among the worst-hit
countries in the world, with an estimated national HIV
prevalence of 26% among adults 15 to 49 years in 2010.
Second, the country started its HIV response early, as
illustrated by the inclusion of HIV/AIDS in the National
Development Plan in the early 1990s [23]. Third, Swaziland
has regularly reported program outcomes since the onset of its
priority national treatment program in 2004 [24]; yet its routine
program and surveillance data continue to have limitations.
This study thus aimed to assess outcome and impact, using
existing data on key programmatic indicators, and to build
evaluation capacity through a country-owned process.
Swaziland demography
The Kingdom of Swaziland is a Southern African country with
an estimated population of 1.2 million people in 2010. About
77% of the population lives in rural areas [25]. Women of
childbearing age (15-49 years) make up 26.2% of the
population [26] and about 40% of the population are children
under 15 years of age. The total fertility rate is estimated at an
average of four births in a woman’s lifetime as of 2007,
compared with 6.4 births in 1986. The life expectancy at birth
has drastically worsened over the two decades of HIV spread,
from 56 years in 1986 to 45.1 years in 2007. Antenatal care
(ANC) attendance in Swaziland is high: 97% of women make at
least one ANC visit during their pregnancy and 79% make at
least four ANC visits [26].
HIV and Tuberculosis Programs
A national response to the HIV epidemic was documented as
early as 1987. The National Emergency Response Council on
HIV and AIDS (NERCHA), established in 2003, produced two
National multi-sectoral HIV and AIDS Strategic Plans (NSP I
2003-2005 and NSP II 2006-2008) that aimed to address HIV
prevention through e.g. behavioral change communication and
promotion of condom use. A 2008 review of the NSP II resulted
in the development of the National multi-sectoral Framework
for HIV and AIDS (2009-2014) that proposes an evidence-
based management approach [27].
The Antiretroviral Therapy (ART) program was launched in
2004 by the Ministry of Health and Social Welfare. Scale up
was implemented in three phases: the first phase established
ART services in Swaziland’s six major hospitals; the second
phase expanded ART delivery to five health centers and some
private clinics; in the third phase more private as well as public
clinics were added. The number of facilities providing HIV care
increased from 19 in 2006 to 114 in 2010 after ART care was
decentralized to peripheral clinics serviced by staff from the
main clinics in 2008. In parallel with this increased service
availability, new treatment guidelines in 2009 expanded the
criteria for patient eligibility for enrolment onto ART to all
HIV/TB co-infected patients, all HIV-infected children younger
than 24 months and all people living with HIV/AIDS (PLWH)
with a CD4 count below 350/mm3, following an earlier 200/mm3
threshold.
A Voluntary Counseling and Testing (VCT) program has
been implemented since 2002. Since 2007, HIV Testing and
Counseling (HTC) was implemented with priority, including a
shift from patient-initiated to provider-initiated counseling and
testing, as part of the standard of care in health facilities
offered to all patients and clients.
Swaziland instituted PMTCT services within its maternal,
new-born and child health services in 2003. Coverage of
PMTCT services was progressively expanded, from 3 clinics
initially to 150 Health facilities (88% of facilities providing ANC)
by 2010 [28]. High coverage of PMTCT services among HIV-
infected pregnant women is facilitated by the high antenatal
care attendance. Since 2003 focus was on the reduction of
mother-to-child transmission among HIV-infected women
through single-dose Nevirapine, but in recent years more
attention is given to primary prevention of HIV, prevention of
unintended pregnancies among HIV-infected women and
provision of treatment, care and support for HIV-infected
women and their families [29,30].
To determine the HIV status of exposed infants, the country
started deoxyribonucleic acid polymerase chain reaction (DNA
PCR) testing using dried blood spot (DBS) in 2007, allowing for
early infant diagnosis of HIV from as early as 6 weeks of age.
As of 2010, 131 (49%) of all facilities are capable of collecting
DBS samples for HIV testing using DNA PCR. All DBS
samples are sent to the National Reference Laboratory for
DNA PCR tests, which performs about 860 tests per month
[28].
Tuberculosis control has historically been the responsibility
of the national TB center. In 2006, national coordination and M
& E of TB control was transferred to the newly established
National TB Control Program (NTCP), while the national TB
center kept responsibility for clinical duties. Collaboration
between the NTCP and the Swaziland National AIDS Program
(SNAP) through the National TB/HIV Steering Committee was
established in 2007, facilitating sharing of information and
consolidating efforts in the management of HIV/TB patients. As
of 2010, 51 TB treatment initiation sites provide both TB
treatment and ART for TB patients co-infected with HIV. In
response to the emerging threat of multidrug-resistant and
extensively drug-resistant tuberculosis (MDR/XDR-TB), a
national referral hospital for MDR-TB became operational in
2009 and four more regional hospitals initiate treatment and
manage MDR-TB since 2011.
Program Impact in Swaziland Using Triangulation
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All primary healthcare services in Swaziland are free to
patients, including antiretroviral treatment, tuberculosis
treatment and antenatal care. Patients however need to pay for
all hospital admissions, irrespective of cause.
Methods
HIV data triangulation in Swaziland
The current study aimed to address the key questions listed
in Table 1, which were agreed between the Ministry of Health
Monitoring and Evaluation Team and key partners in a
consensus workshop (2011), as representing the priority
questions for Swaziland’s national HIV/AIDS programs.
Data sources and triangulation methodology
Our analysis follows the standard approach for public health
data triangulation, focusing on trends over time, by population
(age/sex) group, in nationally aggregated data from health
facilities assembled in the national Health Management
Information System (HMIS), and from population-based health
and demographic surveys and census. Each dataset is
assessed for consistency, representativeness and quality over
time, with subsequent triangulation among the different data
sets focusing on the consistency of patterns over time and by
population groups.
The main data sources were program records and patient
registries from the HTC, ART, TB and PMTCT programs, two-
Table 1. Key questions, by intervention.
1. Common across all interventions
• How has the coverage of key interventions evolved from 2003 to 2010?
• Are available data of such completeness, representativeness and quality
(including consistency or changes over time) as to allow assessment of impact
of interventions and trends in the national population?
2. HIV Testing and Counseling (HTC)
• Is the uptake of HTC associated with enrolment on and coverage of ART
over time?
3. ART
• Given coverage of ART (in numbers and as proportion of HIV-infected in
need), is it plausible that ART has reduced adult and/or infant case fatality and
mortality among patients admitted in hospitals?
• Given coverage of ART (in numbers and as proportion of HIV-infected in
need), is it plausible that ART has reduced adult and/or infant mortality at a
population level – from either vital registration or census or national household
survey data?
4. HIV/TB
• Can time trends in TB case notifications, estimated TB incidence, mortality,
co-infection with HIV, and DOTS treatment outcomes be plausibly related to
HIV prevalence, coverage of ART and combined TB/HIV interventions such as
isoniazid (IPT) or cotrimoxazole prophylactic treatment (CPT)?
5. PMTCT
• How has mortality among infants (less than 1 year including neonates) and
children 1 to 4 years developed, at population level and in hospitals? To what
extent can reductions plausibly be attributed to PMTCT uptake among women
HIV-tested, given HIV infection rates in pregnant women?
yearly HIV sentinel surveillance among women attending ANC
[31], annual data on morbidity and mortality registered in health
facilities and hospitals assembled in the national HMIS, the
2007 Population Census [25] and 2007 Demographic and
Health Survey (DHS) [26]. In addition, we used national-level
estimates of incidence, prevalence, AIDS deaths and
population size produced with the internationally agreed HIV
epidemic model Spectrum, developed by UNAIDS and
technical partners [32]. These databases are available at
national and sub-national level, but since Swaziland is a small
country and the socio-economic, demographic and health
situation does not significantly differ across regions, this study
focuses on data at national level. Data are disaggregated by
age and sex where appropriate. There was no need for special
ethical committee clearance because existing secondary data
sources were used. The data sources, including their validity
and completeness, are described in Table S1 in the online
appendix.
An additional source considered was the vital statistics from
the Department of Births, Marriages and Deaths. While
potentially a uniquely detailed and continuous dataset on
population-level mortality, however, concerns about varying
completeness, representativeness and accuracy, as well as
lack of collaboration with MoH led us to exclude this source
from the triangulation.
Analysis
Swaziland’s hospital monitoring information system captures
in-patient admissions from all public hospitals, including the
reason for admission (diagnosis based on ICD-9 coding
system) and discharge status (e.g. dead, discharged). For the
purpose of this study, in-patient case fatality rate (CFR) is
defined as the proportion of patients admitted to hospital who
died in a given year. Numbers of tuberculosis notifications,
admissions and deaths were standardized according to
estimated population size, and presented as rates per 100,000
population members per year. Infant population size was
estimated according to the population age distribution as
sampled by the 2007 DHS.
Results
Prevalence and Incidence
Among pregnant women tested in HIV sentinel sero-
surveillance, HIV prevalence increased from 3.9% in 1992 to a
peak of 42.6% in 2004, after which prevalence has stabilized at
just above 40% until 2010 (Figure 1) [31]. Using these data in
the Spectrum model, SNAP with UNAIDS estimate that HIV
incidence in adults aged 15-49 years had peaked at 4.6% in
Swaziland in 1998, followed by a consistent downward trend to
2.6% in 2010, with adult prevalence in the overall adult
population stable at around 26% since 2006 [32].
HIV testing and counseling and coverage of
antiretroviral therapy
In 2010 alone, an estimated 244 per 100,000 adults 15 years
and above received HIV testing and counseling in a HTC clinic,
Program Impact in Swaziland Using Triangulation
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according to program records [33]. In 2006-7, 36% of women
aged 15-49 and 17% of men aged 15-49 reported to have ever
received an HIV test and to know its result [26]. The number of
HIV tests administered increased from almost 60,000 in 2007
to more than 160,000 in 2010 (Figure 2A). The proportion of
HIV tests with a positive (infected) result fell from 47% in 2007
to 22% in 2010. Swaziland has made substantial progress in
providing ART to people in need, with estimated coverage
increasing from 46% in 2005 to 72% [95% CI 67-76%] in 2010
[33], where coverage is defined as the ratio of people living
with HIV/AIDS (PLWH) on treatment relative to the Spectrum-
estimated number of PLWH who are eligible for treatment
according to the national guidelines.
Mortality estimates
Swaziland, like most sub-Saharan countries, does not have a
well-functioning reliable system for registering births and
deaths; therefore mortality trends can only be assessed from
periodic household surveys, the ten-yearly national population
census, and small-scale longitudinal research studies. Based
on Census, the crude, all-age death rate increased from 7.6 to
18 per 1,000 from 1997 to 2007; or 2.8 to 16.8 per 1,000 for the
15-49 year age group. Over the same period, the estimated
infant mortality rate increased from 78 to 107 per 1,000, while
the under-5 mortality rate increased from 106 to 167 per 1,000
[25]. The 2007 DHS estimated age-specific adult (aged 15-49
years) mortality for the six years before the survey using sibling
survivorship history. Mortality for men and women were
estimated as 14.4 deaths per 1,000 person years [26] for the
2001-2007 period, consistent with the trend in Census data
Figure 1.  HIV prevalence and incidence over time.  
doi: 10.1371/journal.pone.0069437.g001
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from 1997 to 2007. Furthermore, Spectrum estimated HIV/
AIDS attributable mortality for adults aged 15-49 years at 12.8
per 1,000 person years in 2007 [32].
In-patient case fatality rate
In-patient case fatality rates for AIDS-attributed admissions
as well as all-cause admissions in females aged 15 or older
rapidly rose from 2001 to a peak in 2004-5, followed by a
gradual decline until 2009 (Figure 3A). For children, case
fatality rates for in-patients diagnosed with HIV/AIDS started
declining from around 2004, with corresponding though less
marked declines for inpatient deaths from all causes (Figure
3B). These declines coincided with, or slightly preceded, the
start of roll-out of ART and PMTCT. For TB, the case fatality
rate among adult in-patients remained at around 30% between
2004 and 2010, while it dropped slightly in children admitted
with TB from 2007. All-cause case fatality rates were higher for
adult males than females since 2005.
All-cause admissions and deaths
Figure 4 shows population-standardized in-patient
admissions and deaths, for males and females separately and
for adults aged 15-49 by five-year age bands. In general, there
are more admissions and deaths for females than for males,
even though we excluded maternity-related admissions.
Numbers of all-cause admissions have stabilized or slightly
increased for most age groups since 2005, whereas numbers
of deaths tended to decrease after the decentralization of ART
in 2007-8 for women and men in all age groups.
Retention and survival on antiretroviral therapy
Based on the national ART patient registry, significant losses
occur among both adult and pediatric patients enrolled on ART,
especially within the first six months after enrolment on ART
(Figure 5). These losses include deaths, loss-to-follow-up and
patients stopping treatment. Patient retention rates improved
over consecutive calendar years. For the cohort of adults
enrolled in 2009, the 12-month retention was 84%, just below
the WHO target of 85%, compared to only 75% for the cohort
of adult patients enrolled in 2007. For children enrolled in 2009,
the 12-month retention was 86%, above the target.
Tuberculosis and TB/HIV co-morbidity
Swaziland remains among the countries with the highest TB
disease incidence rates, estimated at 1,290 per 100,000
person years (95% CI 1,060-1,530) as of 2010 [34]. TB is a
common and recurring opportunistic infection among HIV
patients and ART can reduce the incidence and mortality of TB
in HIV-infected people [35]. Around 80% of patients with active
TB in Swaziland are also HIV-infected, and this proportion has
been stable over the period 2006 to 2010 (Figure 6A). By 2010,
according to TB program records, coverage of HIV screening
among TB patients had reached 86%, coverage of CPT among
TB/HIV co-infected patients 93%, and coverage of ART for
TB/HIV co-infected patients 35%. Meanwhile, TB case
notifications continued to increase until 2009, for both new
pulmonary, new extra-pulmonary and relapse cases (Figure
6B). When disaggregated by age and sex, the largest and
steepest increases in TB case notifications were in the age
groups with highest HIV prevalence: men 35-44 years and
women 25-34 years. The incidence of notified MDR-TB, which
is associated with very high mortality even in the presence of
Figure 2.  Uptake of HIV testing and counseling (A) and (B) estimated numbers of PLWH [32], according to ART
eligibility/need of actual enrolment on ART, at the end of every year.  
doi: 10.1371/journal.pone.0069437.g002
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ART, doubled from 9.8 new cases per 100,000 person years in
2007 to 20.1 new cases per 100,000 person years in 2010 [36].
Prevention of mother to child transmission
An estimated 11,000 infants were exposed to HIV in 2010,
out of a total 35,000 births estimated for that year [32]. The
percentage of HIV-exposed babies testing HIV-positive with
DNA PCR methods dropped from 24% in 2007 to 12% in 2010.
In parallel, in-patient all-cause case fatality rates fell sharply for
both infants aged 0-1 year and children aged 1 to 4 years
(Figure 7).
Discussion
The lead and interest taken by the Ministry of Health of
Swaziland facilitated this first comprehensive analysis of HIV
and TB program outcomes and impact using triangulation with
data available across systems and reporting levels.
The spread of HIV in Swaziland started later than in most
other sub-Saharan countries, with a peak in HIV incidence in
the late 1990s. Estimated adult incidence has declined since
the early 2000s, before the roll-out of ART. A declining
incidence and stable prevalence (since 2004) implies that
morbidity and mortality has declined. It is however unclear to
what extent these recent changes in incidence, mortality and
morbidity can be attributed to ART, PMTCT and HTC services
rolled out since 2003, to HIV prevention interventions, and/or to
intrinsic epidemic dynamics.
HIV testing and counseling and coverage of
antiretroviral therapy
The halving of test positivity rates captured in the HIV testing
and counseling database probably reflects the progressively
increasing coverage of especially provider-initiated HIV testing
and counseling among lower-risk populations.
Impact of ART on mortality and morbidity
Census all-cause mortality estimates show a drastic increase
between 1997 (just before the peak in HIV incidence) and 2007
(close to the estimated peak in mortality due to AIDS). Without
data for intermediate and subsequent years, however, as yet
not much can be inferred about the effect of ART on mortality.
As a proxy for population-level mortality trends, we
investigated in-patient case fatality rates. Early evidence of the
impact of the recent health sector responses is suggested by
on-going declines in in-patient case fatality rates among infants
(Figure 7) and children (Figures 3 and 7). Trends for adults are
also somewhat suggestive of program impact (Figure 3). These
trends are similar to those observed in HIV and TB impact
assessments in Botswana [15].
The higher case fatality rate for adult males compared to
adult females from 2005 could be indicative of differential
access to treatment, with females accessing health facilities
more frequently and showing higher ART coverage than men
(79% vs. 58% of PLWH in need in 2010). The steep decrease
in number of hospital admissions from 2001 to 2004 may partly
reflect that, before ART became available, very sick AIDS
patients occupied beds for longer, resulting in lower availability
of beds for new patients. The high in-patient case fatality rate
Figure 3.  Case fatality rates among in-patients according to hospital cause-of-death coding registered in the health
management information system, in relation to Spectrum-estimated AIDS deaths, for (A) adults (aged 15+) and (B) children
(aged 0-14) [32].  
doi: 10.1371/journal.pone.0069437.g003
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of AIDS patients could also have served as a psychological
deterrent for patients to go to hospital.
As the Swaziland ART program improved and expanded
over time, consecutive yearly cohorts of patients enrolled into
ART showed improved retention during the first twelve months
of treatment, but long-term retention is still poor. The persistent
loss during the first six months of treatment is likely explained
by late presentation for HIV/AIDS care, with up to 56% of
patients having progressed to WHO clinical stage 3 or 4 by
time of ART enrolment in 2010 [37]. Interventions that may
contribute to progressively improving retention of patients
include better adherence counseling services, simplified ART
regimens with less pill burden and/or less severe side effects,
and improved patient tracking and tracing systems.
A 2004 study used an undertaker’s data on numbers of
funerals and coffin sales to infer changing patterns of mortality
in Swaziland from late 1998 to early 2002 [38]. Significant
increases in numbers of registered funerals were found in the
age group 0-4 years, from around 300 in 1999 to 900 in 2001,
and for the age group 20-49 years, from around 400 in 1999 to
Figure 4.  Population standardized number of hospital admissions for (A) females and (B) males aged 15-49 and
population standardized number of hospital deaths for (C) females and (D) males aged 15-49.  
doi: 10.1371/journal.pone.0069437.g004
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900 in 2001. This proved a good source to assess mortality
trends, since the specific undertaker operated nationally and
owned a large market share. Also in rural Malawi, coffin sales
and funerals registered by undertakers proved a useful
indicator for time patterns in AIDS-related mortality [18]. Given
Swaziland’s lack of functioning Vital Registration, trends in
Figure 5.  Proportion of patients retained over time after ART enrolment for (A) adults (aged 15+), and (B) children (0-14
years).  
doi: 10.1371/journal.pone.0069437.g005
Figure 6.  TB and HIV co-infection rates, coverage of TB/HIV interventions, according to NTCP registry (A) and TB
notifications (B).  
doi: 10.1371/journal.pone.0069437.g006
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funeral and coffin sales could similarly be a useful data source
to add to future triangulations, especially when including a
before-ART baseline period.
Two large initiatives recently launched in Swaziland, the
Swaziland HIV Incidence Measurement Survey (SHIMS) and
the Maximizing ART for Better Health and Zero New Infections
(MaxART) [39,40] project, should help improve estimates of
HIV and TB incidence, their trends and program impact
between now and 2014. First findings from SHIMS estimated
national HIV incidence at 2.4% per annum and national HIV
prevalence at 31% for the 18-49 age group, for 2012 [41].
Population-level data on all-cause mortality from the
forthcoming 2017 population census and 2013/14 DHS will
provide more conclusive evidence of the impact of ART on
mortality trends.
Tuberculosis and HIV co-infection
In contrast to recent declines in TB/HIV co-infection rates in
Botswana, from 80% in 2003 to 66% in 2009 [15], and Malawi,
Figure 7.  In-patient case fatality rate, population standardized hospital admissions and deaths, among infants (0-1 year)
and children (1-4 years).  
doi: 10.1371/journal.pone.0069437.g007
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from 70% in 2006 to 60% in 2009-10 [42], the TB/HIV co-
infection rate has stayed level at around 80% in Swaziland
from 2006 to 2010. Since these three countries scaled-up ART,
PMTCT and HTC over roughly the same period, the difference
may rather be explained by the difference in the underlying HIV
epidemics, with HIV prevalence having stabilized and started to
decline several years earlier in Malawi and Botswana than in
Swaziland. At the other extreme, neighboring South Africa
documented an ongoing increase in TB/HIV co-infection rates,
from 52% in 2005, to 60% in 2010, and 65% in 2011 [34],
which may be explained by a comparatively lower ART
coverage, at only 36% [95% CI 30-43%] of people living with
HIV/AIDS in need in 2008 [43].
TB notifications by the national TB program have historically
under-reported real numbers of TB cases. According to WHO
estimates, the increase in notifications from 2001 to 2009
parallels an increase in total TB disease incidence, while the
case detection rate has been stable at around 70% [34]. The
full impact of increased priority given recently to TB control,
with strengthened case finding, improved diagnostic methods
and reporting systems; routine screening for TB of all HIV
patients and all patients visiting out-patient departments since
2009; initiation of all HIV-infected patients on INH prophylactic
therapy to prevent TB since 2011 [44,45]; and recent expanded
ART enrolment for all TB/HIV co-infected patients, as per
Swaziland’s 2009 revised ART policy, should become apparent
in NTCP data over coming years.
Prevention of mother to child transmission
Assessing the impact of the overall PMTCT program on the
mortality of infants and children aged one to four is challenging,
but the observed downward all-cause hospital case fatality
trends for these groups are encouraging. Infant in-patient
admissions increased since 2007 – this is likely a result of the
Integrated Management of Acute Malnutrition program that
started in 2007, where the focus for treating malnourished
children was shifted to hospitals [46]. An evaluation of the
effectiveness of the national PMTCT program, led by the
Ministry of Health (MoH) that focuses on infant outcomes at 6-8
weeks post-partum, started in 2012 and is on-going [9,47].
The steep decline in AIDS case fatality rates among admitted
children (from 40% in 2004 to 17% in 2010) may reflect an
impact of ART among infants and children – or alternatively, be
an effect of expanding coverage of HIV diagnosis, including
among children previously not recognized as having HIV/AIDS.
Recommendations
The current triangulation has enabled the national programs
to understand that showing impact is possible. Bringing
together all in-country partners to work on this assessment
proved to be a main challenge. Broader processes may be
needed to facilitate effective partnerships, co-investment in
common M & E frameworks, and country-led platforms of
strategic information that international donors also support and
use [48,49].
National authorities adopted the following recommendations
based on the final study report [22]:
1 To further strengthen collaboration between TB and HIV
programs, including a progressive linkage and integration of
monitoring and reporting systems.
2 To review and strengthen the health management and
information system (HMIS) and underlying data collection
systems, for improved data quality. This process is on-going,
notably with an upgrading of the current cause of disease and
death classification guidance, from ICD-9 to ICD-10.
3 To establish mechanisms of collaboration between the
departments of Births, Marriages and Deaths (BMD), and M &
E in the Health Sector: This should ensure information sharing
and accurate vital registration of deaths − with causes
classified according to the conditions diagnosed in health
facilities, hospitals or by the ART and TB programs. The
committee currently reviewing the HMIS indeed includes
members from the BMD to ensure collaboration.
4 For the ART program to further strengthen tracking,
recording and tracing of patients enrolled on ART, to improve
understanding and actual retention of patients.
Limitations
The limitations of this study are two-fold: the first being
related to the triangulation approach and second, the sources
of data used.
Limitations inherent to public health triangulation [10] include
that the data used were not originally collected for a systematic
impact evaluation, notably they lack comparison/control
groups. As a result, associations observed between
intervention scale-up and health response (over time, by
population group or among regions) do not necessarily indicate
causal relationships.
For data sources used, the key limitations are summarized in
Table S1 in the online appendix. Like other low-income African
countries, Swaziland’s national health monitoring and
information system (HMIS) suffers gaps and inconsistencies in
data (due to changing, sub-optimal and sometimes parallel
data collection, entry and reporting systems and tools), delays
in reporting from health facility to regional and national levels,
and aggregation of data at the national level which results in
the loss of detailed data needed for in-depth analysis. A major
shortcoming of the HMIS is the lack of unique patient
identifiers, making linkage across programs impossible. These
weaknesses probably reduced the power to assess ART and
PMTCT impact from hospital in-patient data. In addition to
these general problems with the HMIS, there are challenges
with clinical diagnosis, in particular cause-of-death recording.
For the national ART program, a 2009 external data quality
assessment reported uncertainty about the precise number of
people on ART, with some over-reporting identified in several
sites [50].
For 2010, the NTCP reported that only 35% of HIV co-
infected TB patients newly diagnosed with TB were receiving
ART – much below the overall 70% coverage of ART among all
people living with HIV. This inconsistency illustrates that data
from SNAP and NTCP are not synchronized properly. Efforts to
harmonize these two parallel systems are being discussed.
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Conclusion
Seven years after the launch of its ART, PMTCT and HTC
programs, Swaziland is demonstrating effective intervention
coverage and early evidence of impact on AIDS-related
mortality in hospitals. This assessment could not yet capture
the full impact of the 2009 revision of HIV control policies to
scale-up provider-initiated testing for HIV, screening HIV
patients for TB, screening TB patients for HIV, and ART for a
broadened set of patients including all TB/HIV co-infected
patients. Future similar triangulations, based on more years of
progressively better-quality and population-based data, are
expected to show more prominently and more conclusively the
significant impact that the national HIV program, with support
from partners, has started to realize.
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